Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Colorectal Neoplasms 26Rectal Neoplasms 19Colonic Neoplasms 18Leukemia 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Lymphoma 11Stomach Neoplasms 9Burkitt Lymphoma 7Pancreatic Neoplasms 5Leukemia, Biphenotypic, Acute 4Esophageal Neoplasms 4Adenocarcinoma Of Esophagus 4Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3Neoplasm Metastasis 3Lymphoma, Large B-Cell, Diffuse 3Dendritic Cell Sarcoma, Interdigitating 3Lymphoma, Mantle-Cell 2Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Thrombocytopenia 1Sarcoma 1Rhabdoid Tumor 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Osteosarcoma 1Neutropenia 1Metastatic Small Intestinal Adenocarcinoma 1Metastatic Pancreatic Adenocarcinoma 1Medulloblastoma 1Leukemia, Myelomonocytic, Juvenile 1Hydatidiform Mole 1

Interventions

Radiotherapy 13Temozolomide 12Carmustine 5Chemotherapy, Adjuvant 3Radiosurgery 2Radiation 2Immunohistochemistry 2Everolimus 2Bevacizumab 2veliparib 1vatalanib 1sagopilone 1rubitecan 1mercaptoundecahydrododecaborate 1lonafarnib 1imetelstat 1beta-D-glucosylisophosphoramide mustard 1azurin (50-77) 1Tamoxifen 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Proton Therapy 1Perfusion Magnetic Resonance Imaging 1O(6)-benzylguanine 1Microarray Analysis 1Methotrexate 1Lomustine 1Leucovorin 1Irinotecan 1In Situ Hybridization, Fluorescence 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Gliosarcoma × Leucovorin × Clear all
NCT00082797 2023-06-15

High-Dose Methotrexate and Leucovorin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Eastern Cooperative Oncology Group

Phase 2 Completed
36 enrolled
CNSSarcoma

Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡